Senti Biosciences Holdings, Inc. (SNTI)
NASDAQ: SNTI · Real-Time Price · USD
0.4338
-0.0032 (-0.73%)
At close: Jul 20, 2026, 4:00 PM EDT
0.4477
+0.0139 (3.20%)
After-hours: Jul 20, 2026, 7:34 PM EDT
Senti Biosciences Holdings Employees
Senti Biosciences Holdings had 39 employees as of December 31, 2025. The number of employees increased by 5 or 14.71% compared to the previous year.
Employees
39
Change (1Y)
5
Growth (1Y)
14.71%
Revenue / Employee
$974
Profits / Employee
-$1,321,718
Market Cap
13.51M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 39 | 5 | 14.71% |
| Dec 31, 2024 | 34 | -14 | -29.17% |
| Dec 31, 2023 | 48 | -74 | -60.66% |
| Dec 31, 2022 | 122 | 33 | 37.08% |
| Dec 31, 2021 | 89 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Lunai Bioworks | 29 |
| Citius Pharmaceuticals | 23 |
| IN8bio | 18 |
| Psyence Biomedical | 12 |
| Cocrystal Pharma | 10 |
| Intensity Therapeutics | 7 |
| KALA BIO | 6 |
| Phio Pharmaceuticals | 6 |
SNTI News
- 4 days ago - Senti Biosciences Holdings Registration statement: Registration filing - Filings
- 5 days ago - Senti Bio announces transaction to spin off Gene-Circuit-enabled pipeline - TheFly
- 5 days ago - Senti Biosciences Holdings Proxy statement: Proxy filing - Filings
- 5 days ago - Senti Biosciences Holdings, Inc. Announces a Strategic Transaction to Unlock Value for its Gene-Circuit-Enabled Pipeline, Including SENTI-202, and to Sharpen its Focus on Next-Generation Controllable Genetic Medicines Powered by its Regulator Dial™ Technology Platform - GlobeNewsWire
- 4 weeks ago - Senti Biosciences Holdings Registration statement: Registration filing - Filings
- 2 months ago - Senti Bio completes Type B RMAT meeting with FDA on SENTI-202 - TheFly
- 2 months ago - Senti Biosciences Holdings Earnings release: Q1 2026 - Filings
- 2 months ago - Senti Biosciences Holdings Quarterly report: Q1 2026 - Filings